The interactions of dendritic cells with antigen-specitic, regulatory T cells that suppress autoimmunity

被引:99
作者
Tarbell, KV
Yamazaki, S
Steinman, RM
机构
[1] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
[2] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA
关键词
dendritic cells; regulatory T cells; autoimmunity; NOD mice; tolerance;
D O I
10.1016/j.smim.2006.01.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) are important for several aspects of the development and function of CD4+ CD25+ regulatory T cells (Tregs), which are critical for maintaining peripheral tolerance and preventing autoimmunity. In cultures from human thymus, dendritic cells (DCs) conditioned with thymic stromal lymphopoietin (TSLP) mediate the production of Tregs from CD4+ CD25- thymocytes. In cultures from mouse lymphoid organs, CD86-rich DCs induce the proliferation and improved suppressive function of antigen-specific Tregs. DC-expanded, antigen-specific Tregs show greatly enhanced efficacy relative to polyclonal populations in blocking experimental autoimmunity. In several animal models including NOD diabetes, Tregs directed to one autoantigen are able to block autoimmunity induced by multiple antigens from the target organ. Distinct states of DC differentiation or maturation are likely to be important for the emerging roles of DCs in the biology of Tregs, particularly the control of autoimmunity in an antigen-dependent manner. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 108 条
[71]   Policing the regulators [J].
Sakaguchi, S .
NATURE IMMUNOLOGY, 2001, 2 (04) :283-284
[72]   B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes [J].
Salomon, B ;
Lenschow, DJ ;
Rhee, L ;
Ashourian, N ;
Singh, B ;
Sharpe, A ;
Bluestone, JA .
IMMUNITY, 2000, 12 (04) :431-440
[73]   Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+ CD25+ regulatory T cells in the regional lymph node [J].
Samy, ET ;
Parker, LA ;
Sharp, CP ;
Tung, KSK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06) :771-781
[74]   CHARACTERIZATION OF THE EXTRACELLULAR-MATRIX CONTAINING GIANT PERIVASCULAR SPACES IN THE NOD MOUSE THYMUS [J].
SAVINO, W ;
CARNAUD, C ;
LUAN, JJ ;
BACH, JF ;
DARDENNE, M .
DIABETES, 1993, 42 (01) :134-140
[75]   Peripheral autoantigen induces regulatory T cells that prevent autoimmunity [J].
Seddon, B ;
Mason, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :877-881
[76]   IMMUNOSTIMULATION CIRCUMVENTS DIABETES IN NOD LT MICE [J].
SERREZE, DV ;
HAMAGUCHI, K ;
LEITER, EH .
JOURNAL OF AUTOIMMUNITY, 1989, 2 (06) :759-776
[77]   Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization [J].
Setoguchi, R ;
Hori, S ;
Takahashi, T ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :723-735
[78]   Regulatory T cells in autoimmmunity [J].
Shevach, EM .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :423-449
[79]   CD4+CD25+ suppressor T cells:: More questions than answers [J].
Shevach, EM .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :389-400
[80]   Control of intestinal inflammation by regulatory T cells [J].
Singh, B ;
Read, S ;
Asseman, C ;
Malmström, V ;
Mottet, C ;
Stephens, LA ;
Stepankova, R ;
Tlaskalova, H ;
Powrie, F .
IMMUNOLOGICAL REVIEWS, 2001, 182 :190-200